Wang Xiaodong
SEC CIK 1662982 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ONC | BeOne Medicines Ltd. | Dir, COB, Scientific Advisory Brd | 0 | — | $118.01M | 46 | 2021-07-01 | 2026-09-08 |
Most active insiders at ONC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | OYLER JOHN | CEO, Dir | — | $327.88M |
| 2 | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | — | $13.37M |
| 3 | Wu Xiaobin | Pres, COO | — | $8.75M |
| 4 | Lee Chan Henry | SVP, GC | — | $7.95M |
| 5 | Wang Lai | Pres, Gbl Head of R, D | — | $1.17M |
| 6 | Sanders Corazon (Corsee) D. | Dir | — | $961.2K |
| 7 | Rosenberg Aaron | CFO | — | $524.4K |
| 8 | BAKER BROS. ADVISORS LP | Dir | — | $262.0K |
| 9 | Ball Titus B. | Principal Accounting Off | — | $127.3K |
| 10 | Dugan Margaret | Dir | — | $65.6K |
Transactions 46
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-09-10 16:49 | 2026-09-08 | ONC | BeOne Medicines Ltd. | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | S - Sale+OE | $349.10 | -38.3K | 0 | -100% | -$13.37M |
| DT | 2026-09-10 16:49 | 2026-09-08 | ONC | BeOne Medicines Ltd. | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | M - OptEx | $36.90 | +31.0K | 31.0K | New | +$1.14M |
| D | 2026-06-15 17:54 | 2026-06-11 | ONC | BeOne Medicines Ltd. | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | A - Grant | $0.00 | +99.9K | 4.68M | +2% | $0 |
| 2025-11-12 | 2025-11-07 | ONC | BeOne Medicines Ltd. | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | G - Gift | $0.00 | -424.1K | 4.58M | -8% | $0 | |
| 2025-09-11 | 2025-09-09 | ONC | BeOne Medicines Ltd. | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | G - Gift | $0.00 | -148.1K | 5.01M | -3% | $0 | |
| M | 2025-06-25 | 2025-06-24 | ONC | BeOne Medicines Ltd. | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | S - Sale | $265.50 | -2,007 | 607 | -77% | -$532.9K |
| D | 2025-06-12 | 2025-06-10 | ONC | BeOne Medicines Ltd. | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | M - OptEx | $6.50 | +41.8K | 41.8K | New | +$271.4K |
| DM | 2025-06-12 | 2025-06-10 | ONC | BeOne Medicines Ltd. | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | S - Sale+OE | $262.82 | -41.8K | 0 | -100% | -$10.98M |
| D | 2025-06-12 | 2025-06-10 | ONC | BeOne Medicines Ltd. | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | A - Grant | $0.00 | +98.7K | 5.18M | +2% | $0 |
| DM | 2025-05-15 | 2025-05-13 | ONC | BeOne Medicines Ltd. | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | S - Sale+OE | $223.50 | -41.8K | 10.3K | -80% | -$9.33M |
| D | 2025-05-15 | 2025-05-13 | ONC | BeOne Medicines Ltd. | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | M - OptEx | $6.50 | +41.8K | 41.8K | New | +$271.4K |
| DM | 2025-04-16 | 2025-04-14 | ONC | BeOne Medicines Ltd. | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | S - Sale+OE | $242.66 | -41.8K | 7,892 | -84% | -$10.13M |
| D | 2025-04-16 | 2025-04-14 | ONC | BeOne Medicines Ltd. | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | M - OptEx | $6.50 | +41.8K | 41.8K | New | +$271.4K |
| DM | 2025-03-20 | 2025-03-18 | ONC | BeOne Medicines Ltd. | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | S - Sale+OE | $261.29 | -41.8K | 29.7K | -58% | -$10.91M |
| D | 2025-03-20 | 2025-03-18 | ONC | BeOne Medicines Ltd. | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | M - OptEx | $6.50 | +41.8K | 41.8K | New | +$271.4K |
| 2025-03-13 | 2025-03-11 | ONC | BeOne Medicines Ltd. | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | G - Gift | $0.00 | -158.7K | 5.08M | -3% | $0 | |
| MI | 2025-03-06 | 2025-03-04 | ONC | BeOne Medicines Ltd. | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | S - Sale | $254.58 | -8,146 | 5,446 | -60% | -$2.07M |
| DM | 2025-02-06 | 2025-02-04 | ONC | BeOne Medicines Ltd. | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | S - Sale+OE | $225.69 | -41.8K | 1,400 | -97% | -$9.42M |
| D | 2025-02-06 | 2025-02-04 | ONC | BeOne Medicines Ltd. | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | M - OptEx | $6.50 | +41.8K | 41.8K | New | +$271.4K |
| DM | 2025-01-08 | 2025-01-07 | ONC | BeOne Medicines Ltd. | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | S - Sale+OE | $176.50 | -41.8K | 6,939 | -86% | -$7.37M |
| D | 2025-01-08 | 2025-01-07 | ONC | BeOne Medicines Ltd. | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | M - OptEx | $6.50 | +41.8K | 41.8K | New | +$271.4K |
| DM | 2024-12-12 | 2024-12-10 | ONC | BeOne Medicines Ltd. | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | S - Sale+OE | $186.90 | -41.8K | 2,399 | -95% | -$7.81M |
| D | 2024-12-12 | 2024-12-10 | ONC | BeOne Medicines Ltd. | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | M - OptEx | $6.50 | +41.8K | 41.8K | New | +$271.4K |
| DMI | 2024-11-29 | 2024-11-26 | ONC | BeOne Medicines Ltd. | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | S - Sale+OE | $189.97 | -7,883 | 3,608 | -69% | -$1.50M |
| DM | 2024-11-29 | 2024-11-26 | ONC | BeOne Medicines Ltd. | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | S - Sale+OE | $190.10 | -40.5K | 7,388 | -85% | -$7.69M |
| D | 2024-11-29 | 2024-11-26 | ONC | BeOne Medicines Ltd. | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | M - OptEx | $6.50 | +38.5K | 40.5K | +1,916% | +$250.0K |
| 2024-08-14 | 2024-08-12 | ONC | BeOne Medicines Ltd. | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | G - Gift | $0.00 | -301.5K | 5.27M | -5% | $0 | |
| D | 2024-06-07 | 2024-06-05 | ONC | BeOne Medicines Ltd. | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | A - Grant | $0.00 | +109.0K | 5.57M | +2% | $0 |
| I | 2023-12-04 | 2023-11-30 | ONC | BeOne Medicines Ltd. | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | J - Other | $0.00 | -172.4K | 0 | -100% | $0 |
| 2023-12-04 | 2023-11-30 | ONC | BeOne Medicines Ltd. | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | G - Gift | $0.00 | -71.9K | 5.46M | -1% | $0 | |
| D | 2023-06-20 | 2023-06-15 | ONC | BeOne Medicines Ltd. | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | A - Grant | $0.00 | +86.2K | 5.53M | +2% | $0 |
| 2023-03-20 | 2023-03-16 | ONC | BeOne Medicines Ltd. | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | G - Gift | $0.00 | -67.4K | 5.45M | -1% | $0 | |
| DM | 2023-03-10 | 2023-03-08 | ONC | BeOne Medicines Ltd. | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | S - Sale+OE | $226.03 | -67.6K | 43.8K | -61% | -$15.29M |
| D | 2023-03-10 | 2023-03-08 | ONC | BeOne Medicines Ltd. | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | M - OptEx | $0.13 | +67.6K | 67.6K | New | +$8,793 |
| MI | 2023-01-17 | 2023-01-12 | ONC | BeOne Medicines Ltd. | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | S - Sale | $260.52 | -5,000 | 901 | -85% | -$1.30M |
| M | 2023-01-11 | 2023-01-09+ | ONC | BeOne Medicines Ltd. | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | S - Sale | $251.36 | -5,000 | 100 | -98% | -$1.26M |
| MI | 2022-12-15 | 2022-12-13 | ONC | BeOne Medicines Ltd. | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | S - Sale | $211.32 | -3,013 | 1,621 | -65% | -$636.7K |
| 2022-11-30 | 2022-11-28 | ONC | BeOne Medicines Ltd. | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | G - Gift | $0.00 | -52.0K | 5.58M | -0.9% | $0 | |
| I | 2022-11-17 | 2022-11-15 | ONC | BeOne Medicines Ltd. | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | S - Sale | $210.14 | -1,987 | 0 | -100% | -$417.5K |
| 2022-09-08 | 2022-09-06 | ONC | BeOne Medicines Ltd. | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | G - Gift | $0.00 | -33.4K | 5.63M | -0.6% | $0 | |
| M | 2022-08-09 | 2022-08-05+ | ONC | BeOne Medicines Ltd. | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | S - Sale | $197.91 | -11.1K | 4,500 | -71% | -$2.19M |
| MI | 2022-08-09 | 2022-08-05 | ONC | BeOne Medicines Ltd. | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | S - Sale | $193.85 | -5,000 | 0 | -100% | -$969.3K |
| D | 2022-06-24 | 2022-06-22 | ONC | BeOne Medicines Ltd. | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | A - Grant | $0.00 | +83.5K | 5.81M | +1% | $0 |
| M | 2021-11-10 | 2021-11-08 | ONC | BeOne Medicines Ltd. | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | S - Sale | $349.81 | -4,500 | 4,200 | -52% | -$1.57M |
| M | 2021-11-10 | 2021-11-08 | ONC | BeOne Medicines Ltd. | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | S - Sale | $350.04 | -4,500 | 1,300 | -78% | -$1.58M |
| M | 2021-07-01 | 2021-07-01 | ONC | BeOne Medicines Ltd. | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | S - Sale | $348.16 | -4,848 | 0 | -100% | -$1.69M |
Purchase Sale Sale after option exercise All abbreviations